Although the correlation of ESR1 mutations between tumor tissue and plasma is closely associated with medical history of endocrine therapy, this studied population is heterogeneously treated and we had insufficient data to examine whether ESR1 mutation detection is dependent on specific hormone therapies or not. Here, ESR1 is linked to neoplasm.